Research never stops

Top Story

Evotec receives milestone as part of its multi-target alliance with Bayer HealthCare

Hamburg, Germany - 30 September 2014: Evotec AG announced today that its multi-target collaboration with Bayer HealthCare ("Bayer") has reached an important milestone for the transition

- read more

Evotec and its partners awarded public grants to develop new drug candidates to treat multiple sclerosis

Hamburg, Germany - 24 September 2014: Evotec AG announced today that it has entered into three novel research projects for the treatment of Multiple Sclerosis ("MS") supported by research

- read more

Evotec takes legal steps against Andromeda Biotech, Ltd.

Hamburg, Germany - 18 September 2014: Evotec AG announced today after careful evaluation that it will take legal steps against Israel-based Andromeda Biotech, Ltd. to recover all Evotec claims and potential damages that result from recent incidents in relation to DiaPep277®.

- read more
loading weather report
Loading weather report...

Events

Oct 07, 2014 - The 13th Annual BIO Investor Forum

Oct 16, 2014 - 6th Annual Healthcare Investor Conference

Company Presentation September

Building integrated and high-value drug discovery alliances
2014-09_Evotec_Company presentation_September